Skip to main content

VITAL mit Omega-3 und Vitamin D? Zweifel an primärpräventivem Nutzen der beliebten Supplemente

VITAL with omega 3 and vitamin D? Doubts on primary preventive benefits of the popular supplements

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (1999) Dietary supplementation with n‑3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455

    Article  Google Scholar 

  2. 2.

    Bhatt DL, Steg G, Miller M et al (2018) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. https://doi.org/10.1056/NEJMoa1812792

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    ASCEND Study Collaborative Group (2018) Effects of n‑3 fatty acid supplements in diabetes mellitus. N Engl J Med 379(16):1540–1550

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Preßler.

Ethics declarations

Interessenkonflikt

A. Preßler gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Preßler, A. VITAL mit Omega-3 und Vitamin D? Zweifel an primärpräventivem Nutzen der beliebten Supplemente. Kardiologe 13, 5–7 (2019). https://doi.org/10.1007/s12181-018-0293-y

Download citation